nach oben

Erschienen in:

15.06.2020 | IM - REVIEW

The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years

verfasst von: Marco Vitolo, Marco Proietti, Stephanie Harrison, Deirdre A. Lane, Tatjana S. Potpara, Giuseppe Boriani, Gregory Y. H. Lip

Erschienen in: Internal and Emergency Medicine | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Management of atrial fibrillation (AF) may be challenging in clinical practice. Given the complexity of AF patients and the continuous advances in AF clinical management, there is a need for standardized programmes aimed at collecting so-called ‘real-world clinical practice data’ regarding the epidemiology, diagnostic/therapeutic/management practices and assessing adherence to guidelines. Over the past 20 years, the number of registries and surveys based on real-world AF patients has been dramatically increased. In Europe, based on the Euro Heart Survey (EHS) and the EURObservational Research Programme (EORP), a large series of studies based on these prospective, observational, large-scale multicentre registries on AF have been published. This narrative review gives an overview of these two projects on AF led by the European Society of Cardiology, focusing mainly on the contribution that these studies have provided to AF management and patient outcomes. Both the EHS and the EORP registries have collected a large amount of data regarding contemporary clinical practice, and despite some limitations, mainly related to their observational nature, these registries have contributed to our knowledge and clinical management of AF patients.

Proietti M, Lane DA, Boriani G, Lip GYH (2019) Stroke prevention, evaluation of bleeding risk, and anticoagulant treatment management in atrial fibrillation contemporary international guidelines. Can J Cardiol 35:619–633PubMed

Pastori D, Farcomeni A, Saliola M, Del Sole F, Pignatelli P, Violi F, Lip GYH (2018) Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation. Eur J Intern Med 54:34–39PubMed

Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114:119–125PubMed

Gitt AK, Bueno H, Danchin N, Fox K, Hochadel M, Kearney P, Maggioni AP, Opolski G, Seabra-Gomes R, Weidinger F (2010) The role of cardiac registries in evidence-based medicine. Eur Heart J 31:525–529PubMed

Hirsh J, Eikelboom JW, Chan NC (2019) Fifty years of research on antithrombotic therapy: achievements and disappointments. Eur J Intern Med 70:1–7PubMed

Lip GY, Al-Khatib SM, Cosio FG, Banerjee A, Savelieva I, Ruskin J, Blendea D, Nattel S, De Bono J, Conroy JM, Hess PL, Guasch E, Halperin JL, Kirchhof P, Cosio MD, Camm AJ (2014) Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? J Am Heart Assoc 3(4):e001179PubMedPubMedCentral

Mazurek M, Huisman MV, Lip GYH (2017) Registries in atrial fibrillation: from trials to real-life clinical practice. Am J Med 130:135–145PubMed

Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, Bonow RO, Davenport RL, Girgus M, Fonarow GC, Krumholz HM, Legnini MW, Lewis WR, Nichol G, Peterson ED, Rumsfeld JS, Schwamm LH, Shahian DM, Spertus JA, Woodard PK, Yancy CW (2011) The American Heart Association’s recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation 123:2167–2179PubMed

Scholte op Reimer WJMGA, Boersma E, Simoons ML (eds) (2006) (2006) Cardiovascular diseases in Europe. Euro Heart Survey. European Society of Cardiology, Sophia Antipolis

10.

Lee P, Chin K, Liew D, Stub D, Brennan AL, Lefkovits J, Zomer E (2019) Economic evaluation of clinical quality registries: a systematic review. BMJ Open 9:e030984PubMedPubMedCentral

11.

Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey JY, Prins MH, Levy S, Crijns HJ (2005) Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillation. Eur Heart J 26:2422–2434PubMed

12.

Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Alonso-Garcia A, Blomström-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 104:2118–2150PubMed

13.

Boriani G, Proietti M, Laroche C, Diemberger I, Popescu MI, Riahi S, Shantsila A, Dan GA, Tavazzi L, Maggioni AP, Lip GYH (2018) Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. Int J Cardiol 271:68–74PubMed

14.

Lip GYH, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP (2014) A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 16:308–319PubMed

15.

Boriani G, Proietti M, Laroche C, Fauchier L, Marin F, Nabauer M, Potpara T, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Lip GYH (2019) Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. Europace 21:1013–1022PubMed

16.

Boriani G, Proietti M, Laroche C, Fauchier L, Marin F, Nabauer M, Potpara T, Dan GA, Kalarus Z, Diemberger I, Tavazzi L, Maggioni AP, Lip GYH (2018) Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) long-term general registry. Europace 20:747–757PubMed

17.

Lip GYH (2013) EUR Observational research programme: atrial fibrillation general registry pilot phase. Eur Heart J 34:794PubMed

18.

Hsu JC, Akao M, Abe M, Anderson KL, Avezum A, Glusenkamp N, Kohsaka S, Lane DA, Lip GYH, Ma CS, Masoudi FA, Potpara TS, Siong TW, Turakhia MP, Tse HF, Rumsfeld JS, Maddox TM (2016) International collaborative partnership for the study of atrial fibrillation (INTERAF): rationale, design, and initial descriptives. J Am Heart Assoc 5(11):e004037PubMedPubMedCentral

19.

Dudink EAMP, Erküner Ö, Berg J, Nieuwlaat R, de Vos CB, Weijs B, Capucci A, Camm AJ, Breithardt G, Le Heuzey JY, Luermans JGLM, Crijns HJ (2018) The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. Europace 20:929–934PubMed

20.

de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ (2010) Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 55:725–731PubMed

21.

Nieuwlaat R, Prins MH, Le Heuzey JY, Vardas PE, Aliot E, Santini M, Cobbe SM, Widdershoven JW, Baur LH, Lévy S, Crijns HJ (2008) Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J 29:1181–1189PubMed

22.

de Vos CB, Nieuwlaat R, Crijns HJ, Camm AJ, LeHeuzey JY, Kirchhof CJ, Capucci A, Breithardt G, Vardas PE, Pisters R, Tieleman RG (2008) Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. Eur Heart J 29:632–639PubMed

23.

Erküner Ö, Dudink EAMP, Nieuwlaat R, Rienstra M, Van Gelder IC, Camm AJ, Capucci A, Breithardt G, LeHeuzey JY, Lip GYH, Crijns HJ, Luermans JGLM (2018) Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey). Am J Cardiol 122:578–583PubMed

24.

Weijs B, Pisters R, Nieuwlaat R, Breithardt G, Le Heuzey JY, Vardas PE, Limantoro I, Schotten U, Lip GYH, Crijns HJ (2012) Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace 14:184–190PubMed

25.

Fumagalli S, Nieuwlaat R, Tarantini F, de Vos CB, Werter CJ, Le Heuzey JY, Marchionni N, Crijns HJ (2012) Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation. Aging Clin Exp Res 24:517–523PubMed

26.

Proietti M, Laroche C, Nieuwlaat R, Crijns HJ, Maggioni AP, Lane DA, Boriani G, Lip GYH (2018) Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: a comparison between EORP-AF pilot and EHS-AF registries. Eur J Intern Med 55:28–34PubMed

27.

Fumagalli S, Said SAM, Laroche C, Gabbai D, Marchionni N, Boriani G, Maggioni AP, Popescu MI, Rasmussen LH, Crijns HJ, Lip GYH (2015) Age-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: the EORP-AF general pilot registry (EURObservational Research Programme-Atrial Fibrillation). JACC Clin Electrophysiol 1:326–334PubMed

28.

Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin L, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP (2017) Screening for Atrial fibrillation: a report of the AF-SCREEN International Collaboration. Circulation 135:1851–1867PubMed

29.

Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, Witteman JC, Stricker BH, Heeringa J (2013) Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 34:2746–2751PubMedPubMedCentral

30.

Lip GY, Laroche C, Boriani G, Cimaglia P, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Popescu MI, Tica O, Hellum CF, Mortensen B, Tavazzi L, Maggioni AP (2015) Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme pilot survey on atrial fibrillation. Europace 17:24–31PubMed

31.

Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, Kremastinos DT, Breithardt G, Cokkinos DV, Crijns HJ (2007) Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol 49:572–577PubMed

32.

Boriani G, Colella J, Imberti J, Fantecchi E, Vitolo M (2019) Female sex and stroke in atrial fibrillation: an intriguing relationship. Intern Emerg Med 15(2):175–179PubMed

33.

Boriani G, Laroche C, Diemberger I, Fantecchi E, Meeder J, Kurpesa M, Baluta MM, Proietti M, Tavazzi L, Maggioni AP, Lip GYH (2018) Overweight and obesity in patients with atrial fibrillation: sex differences in 1-year outcomes in the EORP-AF general pilot registry. J Cardiovasc Electrophysiol 29:566–572PubMed

34.

Marzona I, Proietti M, Farcomeni A, Romiti GF, Romanazzi I, Raparelli V, Basili S, Lip GYH, Nobili A, Roncaglioni MC (2018) Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients. Int J Cardiol 269:182–191PubMed

35.

Pisters R, Nieuwlaat R, Prins MH, Le Heuzey JY, Maggioni AP, Camm AJ, Crijns HJ (2012) Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace 14:666–674PubMed

36.

Purmah Y, Proietti M, Laroche C, Mazurek M, Tahmatzidis D, Boriani G, Novo S, Lip GYH (2018) Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation. Europace 20:243–252PubMed

37.

Tilz RR, Dagres N, Arbelo E, Blomström-Lundqvist C, Crijns HJ, Kirchhof P, Kautzner J, Temporelli PL, Laroche C, Roberts PR, Pehrson S, Lip GYH, Brugada J, Tavazzi L (2019) Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP atrial fibrillation ablation long-term and atrial fibrillation general pilot registries. Europace 22(2):250–258

38.

Proietti M, Laroche C, Nyvad O, Haberka M, Vassilikos VP, Maggioni AP, Boriani G, Lip GYH (2017) Use of statins and adverse outcomes in patients with atrial fibrillation: an analysis from the EURObservational Research Programme atrial fibrillation (EORP-AF) general registry pilot phase. Int J Cardiol 248:166–172PubMed

39.

Hendriks JL, Nieuwlaat R, Vrijhoef HJ, de Wit R, Crijns HJ, Tieleman RG (2010) Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program. Neth Heart J 18:471–477PubMedPubMedCentral

40.

Pisters R, Nieuwlaat R, Lane DA, Crijns HJ, Lip GYH (2013) Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey. Thromb Haemost 109:328–336PubMed

41.

Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Lip GYH (2016) ‘Real-world’ management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) general pilot registry. Europace 18:648–657PubMed

42.

Lip GY, Laroche C, Ioachim PM, Rasmussen LH, Vitali-Serdoz L, Petrescu L, Darabantiu D, Crijns HJ, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP, Boriani G (2014) Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-atrial fibrillation general registry pilot phase (EORP-AF pilot registry). Eur Heart J 35:3365–3376PubMed

43.

Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833PubMed

44.

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL (2019) Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 321:1261–1274PubMedPubMedCentral

45.

Lane DA, Apostolakis S, Boos CJ, Lip GYH (2011) Atrial fibrillation (chronic). BMJ Clin Evid 2011:0217PubMedPubMedCentral

46.

Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378:417–427PubMed

47.

Boriani G, Imberti JF, Valenti AC, Malavasi VL, Vitolo M (2020) Managing atrial fibrillation: the need for an individualized approach even in the emergency department. Intern Emerg Med 15:9–12PubMed

48.

Guerra F, Brambatti M, Nieuwlaat R, Marcucci M, Dudink E, Crijns HJ, Matassini MV, Capucci A (2017) Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. Europace 19:1922–1929PubMed

49.

Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, Sinagra G, Petrescu L, Tavazzi L, Maggioni AP, Lip GY (2015) Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF pilot general registry. Am J Med 128:509–518.e502PubMed

50.

Nieuwlaat R, Eurlings LW, Cleland JG, Cobbe SM, Vardas PE, Capucci A, López-Sendòn JL, Meeder JG, Pinto YM, Crijns HJ (2009) Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol 53:1690–1698PubMed

51.

Dan GA, Badila E, Weiss E, Laroche C, Boriani G, Dan A, Tavazzi L, Maggioni AP, Crijns HJ, Popescu R, Blommaert D, Streb W, Lip GYH (2018) Arterial hypertension in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme pilot survey on atrial fibrillation. Int J Cardiol 254:136–141PubMed

52.

Lip GYH, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G (2015) Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme pilot survey on atrial fibrillation. Eur J Heart Fail 17:570–582PubMed

53.

Proietti M, Laroche C, Drozd M, Vijgen J, Cozma DC, Drozdz J, Maggioni AP, Boriani G, Lip GYH (2016) Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational Research Programme pilot survey on atrial fibrillation (EORP-AF) general registry. Am Heart J 181:83–91PubMed

54.

Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, Crijns HJ, Tavazzi L, Maggioni AP, Lip GYH (2016) Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Sci Rep 6:30271PubMedPubMedCentral

55.

Proietti M, Raparelli V, Laroche C, Dan GA, Janion M, Popescu R, Sinagra G, Vijgen J, Boriani G, Maggioni AP, Tavazzi L, Lip GYH (2017) Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation. Europace 19:1439–1448PubMed

56.

Fumagalli S, Said SA, Laroche C, Gabbai D, Boni S, Marchionni N, Boriani G, Maggioni AP, Musialik-Lydka A, Sokal A, Petersen J, Crijns HJ, Lip GYH (2018) Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF general pilot registry report. Eur Heart J Cardiovasc Pharmacother 4:172–179PubMed

57.

Berg J, Lindgren P, Nieuwlaat R, Bouin O, Crijns HJ (2010) Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Qual Life Res 19:381–390PubMed

58.

Proietti M, Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Sinagra G, Dan GA, Maggioni AP, Tavazzi L, Lane DA, Lip GYH (2017) Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme pilot survey on atrial fibrillation (EORP-AF) general registry. Europace 19:535–543PubMed

59.

Proietti M, Raparelli V, Olshansky B, Lip GYH (2016) Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial. Clin Res Cardiol 105:412–420PubMed

60.

Fauchier L, Villejoubert O, Clementy N, Bernard A, Pierre B, Angoulvant D, Ivanes F, Babuty D, Lip GYH (2016) Causes of death and influencing factors in patients with atrial fibrillation. Am J Med 129:1278–1287PubMed

61.

Proietti M, Laroche C, Opolski G, Maggioni AP, Boriani G, Lip GYH (2017) ‘Real-world’ atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-atrial fibrillation general registry pilot phase. Europace 19:722–733PubMed

62.

Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH (2018) Improved Outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (atrial fibrillation better care) pathway. Am J Med 131:1359–1366.e1356PubMed

63.

Lip GYH (2017) The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 14:627–628PubMed

64.

Freedman B, Potpara TS, Lip GYH (2016) Stroke prevention in atrial fibrillation. Lancet 388:806–817PubMed

65.

Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457

66.

Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW (1999) Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The stroke prevention in atrial fibrillation (spaf) investigators. Stroke 30:1223–1229PubMed

67.

Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ (2003) A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290:1049–1056PubMed

68.

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 137:263–272PubMed

69.

Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GYH (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093–1100PubMed

70.

Lip GYH, Skjøth F, Nielsen PB, Kjældgaard JN, Larsen TB (2018) The HAS-BLED, ATRIA, and ORBIT bleeding scores in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants. Am J Med 131:574.e513–574.e527

71.

Marcucci M, Lip GY, Nieuwlaat R, Pisters R, Crijns HJ, Iorio A (2014) Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey. Am J Med 127:979–986.e972PubMed

72.

Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, Lip GY, Crijns HJ, Investigators EHS (2008) Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 29:915–922PubMed

73.

Lip GYH, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP (2014) ‘Real-world’ antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am J Med 127:519–529.e511PubMed

74.

Nieuwlaat R, Capucci A, Lip GYH, Olsson SB, Prins MH, Nieman FH, Lopez-Sendon J, Vardas PE, Aliot E, Santini M, Crijns HJ (2006) Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillation. Eur Heart J 27:3018–3026PubMed

75.

Lip GYH, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G (2015) Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF general pilot registry. Europace 17:1777–1786PubMed

76.

Nieuwlaat R, Olsson SB, Lip GYH, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ (2007) Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J 153:1006–1012PubMed

77.

Holstenson E, Ringborg A, Lindgren P, Coste F, Diamand F, Nieuwlaat R, Hj C (2011) Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. Europace 13:23–30PubMed

78.

Ringborg A, Nieuwlaat R, Lindgren P, Jonsson B, Fidan D, Maggioni AP, Lopez-Sendon J, Stepinska J, Cokkinos DV, Crijns HJ (2008) Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 10:403–411PubMed

79.

Lenarczyk R, Mitręga K, Mazurek M, Janion M, Opolski G, Drożdż J, Streb W, Fuglewicz A, Sokal A, Laroche C, Lip GHY, Kalarus Z (2016) Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-atrial fibrillation general registry pilot phase (EORP-AF Pilot). Pol Arch Med Wewn 126:138–148PubMed

80.

Lip GYH, Laroche C, Boriani G, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Maggioni AP, Tavazzi L (2015) Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme atrial fibrillation (EORP-AF) pilot general registry. Europace 17:194–206PubMed

Titel: The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years
verfasst von: Marco Vitolo
Marco Proietti
Stephanie Harrison
Deirdre A. Lane
Tatjana S. Potpara
Giuseppe Boriani
Gregory Y. H. Lip
Publikationsdatum: 15.06.2020
Verlag: Springer International Publishing
Erschienen in: Internal and Emergency Medicine / Ausgabe 7/2020
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02405-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

How valuable is cardiopulmonary exercise testing in patients with severe obesity undergoing bariatric surgery?

CTA-occult traumatic carotid blowout injury

Infections in out-of-hospital and in-hospital post-cardiac arrest patients: comment

Management of antithrombotic therapy in gray areas of venous thromboembolism: a Delphi consensus panel

Approaching acute pain in emergency settings; European Society for Emergency Medicine (EUSEM) guidelines—part 2: management and recommendations